The startup, spun out of nonprofit Accumulus Synergy last August, has built a network connecting pharmaceutical and biotech companies to regulators across more than 70 countries. The new Connector makes that network accessible without leaving the systems companies already use. Getting a drug approved in multiple countries simultaneously requires filing the same information with dozens […]

This story continues at The Next Web